Effect of once-daily indacaterol maleate/mometasone furoate on exacerbation risk in adolescent and adult asthma: a double-blind randomised controlled trial

OBJECTIVE: To investigate the safety and efficacy of QMF149, a once-daily, fixed-dose combination of the long-acting β(2)-agonist (LABA) indacaterol maleate and inhaled corticosteroid (ICS) mometasone furoate (MF) for the treatment of persistent asthma. The hypothesis was that QMF149 would not incre...

Descripción completa

Detalles Bibliográficos
Autores principales: Beasley, Richard W, Donohue, James F, Mehta, Rajendra, Nelson, Harold S, Clay, Michelle, Moton, Allen, Kim, Han-Joo, Hederer, Bettina M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2015
Materias:
Respiratory Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322191/
https://www.ncbi.nlm.nih.gov/pubmed/25649209
http://dx.doi.org/10.1136/bmjopen-2014-006131

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322191/
https://www.ncbi.nlm.nih.gov/pubmed/25649209
http://dx.doi.org/10.1136/bmjopen-2014-006131

Ejemplares similares